Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Microsoft
MSFT
|
$1.04B |
| 2 |
Apple
AAPL
|
$880M |
| 3 |
Merck
MRK
|
$323M |
| 4 |
Medtronic
MDT
|
$317M |
| 5 |
Amazon
AMZN
|
$314M |
Top Sells
| 1 |
Walt Disney
DIS
|
$741M |
| 2 |
NXP Semiconductors
NXPI
|
$597M |
| 3 |
Intuit
INTU
|
$468M |
| 4 |
Meta Platforms (Facebook)
META
|
$447M |
| 5 |
Advanced Micro Devices
AMD
|
$385M |
Sector Composition
| 1 | Technology | 24.73% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Financials | 12.19% |
| 5 | Communication Services | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
X4 Pharmaceuticals
XFOR
$78.6M
| $541K | ﹤0.01% |
2,808
+38
| +1% | +$7.32K |
|
|
IVAC
3002
DELISTED
Intevac Inc
IVAC
| $540K | ﹤0.01% |
74,892
+17,022
| +29% | +$123K |
|
3003
iRadimed
IRMD
$916M
| $536K | ﹤0.01% |
23,526
+551
| +2% | +$12.6K |
|
|
LX
3004
LexinFintech Holdings
LX
$1.02B
| $531K | ﹤0.01% |
+79,200
| New | +$531K |
|
3005
Pampa Energía
PAM
$3.7B
| $529K | ﹤0.01% |
38,383
-10,100
| -21% | -$139K |
|
3006
Gaia
GAIA
$140M
| $525K | ﹤0.01% |
53,117
+707
| +1% | +$6.99K |
|
3007
Pliant Therapeutics
PLRX
$114M
| $525K | ﹤0.01% |
23,105
| – | – |
|
3008
Tiptree Inc
TIPT
$849M
| $525K | ﹤0.01% |
104,500
+12,885
| +14% | +$64.7K |
|
3009
Information Services Group
III
$253M
| $522K | ﹤0.01% |
159,036
+2,034
| +1% | +$6.68K |
|
|
SMED
3010
DELISTED
Sharps Compliance Corp
SMED
| $522K | ﹤0.01% |
55,220
+8,407
| +18% | +$79.5K |
|
3011
Stratus Properties
STRS
$155M
| $521K | ﹤0.01% |
20,429
+122
| +0.6% | +$3.11K |
|
3012
Arq
ARQ
$302M
| $518K | ﹤0.01% |
94,139
+540
| +0.6% | +$2.97K |
|
3013
Chemung Financial Corp
CHMG
$251M
| $512K | ﹤0.01% |
15,056
+5,331
| +55% | +$181K |
|
|
SREV
3014
DELISTED
ServiceSource International, Inc.
SREV
| $512K | ﹤0.01% |
290,980
+74,350
| +34% | +$131K |
|
3015
Eastern Company
EML
$146M
| $508K | ﹤0.01% |
21,047
+9,365
| +80% | +$226K |
|
3016
Genie Energy
GNE
$404M
| $507K | ﹤0.01% |
70,374
+1,631
| +2% | +$11.8K |
|
3017
Gyre Therapeutics
GYRE
$698M
| $505K | ﹤0.01% |
10,686
+407
| +4% | +$19.2K |
|
3018
ADMA Biologics
ADMA
$4.03B
| $501K | ﹤0.01% |
256,937
+1,407
| +0.6% | +$2.74K |
|
3019
IBEX
IBEX
$393M
| $501K | ﹤0.01% |
+26,789
| New | +$501K |
|
3020
Marine Products Corp
MPX
$318M
| $498K | ﹤0.01% |
34,268
+245
| +0.7% | +$3.56K |
|
3021
Abeona Therapeutics
ABEO
$352M
| $496K | ﹤0.01% |
12,644
+112
| +0.9% | +$4.39K |
|
3022
Dyne Therapeutics
DYN
$2.02B
| $490K | ﹤0.01% |
+23,318
| New | +$490K |
|
|
PTVCB
3023
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $488K | ﹤0.01% |
35,552
+528
| +2% | +$7.25K |
|
3024
Riverview Bancorp
RVSB
$106M
| $486K | ﹤0.01% |
92,369
+19,431
| +27% | +$102K |
|
|
CLPR
3025
Clipper Realty
CLPR
$71.2M
| $476K | ﹤0.01% |
67,497
+12,323
| +22% | +$86.9K |
|